Thinly traded micro cap BioSig Technologies (BSGM +41.3%) is up on almost a 12x surge in volume in reaction to its upcoming “telebriefing”
on Tuesday, April 7, to discuss recently acquired Vicromax, a
broad-spectrum antiviral that, it says, has shown strong activity
against COVID-19 in cell cultures.
Clinical trials assessing Vicromax alone and in combination other drugs are next up.
https://seekingalpha.com/news/3558342-biosig-up-41-ahead-of-briefing-on-covidminus-19-candidate
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.